Scientific interest in IGF-1 LR3 extends across multiple research disciplines, including tissue development, regenerative biology, cellular proliferation, and metabolic pathway investigation
In comparison to sulfonylureas, GLP-1RA use was linked to a lower risk of 23 outcomes, including bronchitis, pneumonia, suicidal ideation, chronic obstructive pulmonary disease (COPD), and coagulopathy, and an increased risk of 14 outcomes, including gastroesophageal reflux disease (GERD) nausea, vomiting, sleep disturbances, abdominal pain, and bone pain
Consider setting an early afternoon caffeine cutoff if sleep issues arise
Popular Pathways were identified by analyzing trends in dementia-related publications over the past 10 years using Pathway_ranks (the rank of the pathways based on their yearly count of the literature related to AD)